Photobiomodulation therapy in the modulation of inflammatory mediators and bradykinin receptors in an experimental model of acute osteoarthritis
- 10 October 2016
- journal article
- research article
- Published by Springer Nature in Lasers in Medical Science
- Vol. 32 (1) , 87-94
Abstract
The objective of this study was to evaluate the effects of photobiomodulation therapy (PBMT) on inflammatory indicators, i.e., inflammatory mediators (TNF-α and CINC-1), and pain characterized by hyperalgesia and B1 and B2 receptor activation at 6, 24, and 48 h after papain-induced osteoarthritis (OA) in rats. Fifty-four rats were subjected to hyperalgesia evaluations and then divided randomly into three groups—a control group and two groups OA and OA PBMT group by using laser parameters at wavelength (808 nm), output power (50 mW), energy per point (4 Joules), power density (1.78 W/cm2), laser beam (0.028 cm2), and energy density (144 J/cm2)—the induction of osteoarthritis was then performed with 20-μl injections of a 4 % papain solution dissolved in 10 μl of saline solution, to which 10 μl of cysteine solution (0.03 M). The statistical analysis was performed using two-way ANOVA with Bonferroni’s post hoc test for comparisons between the 6, 24, and 48 h and team points within each group, and between the control, injury, and PBMT groups, and p < 0.05 was considered to indicate a significant difference. The hyperalgesia was evaluated at 6, 24, and 48 h after the injury. PBMT at a wavelength of 808 nm and doses of 4 J, administered afterward, promotes increase at the threshold of pressure stimulus at 6, 24, and 48 h after application and promote cytokine attenuation levels (TNF and CINC-1) and bradykinin receptor (B1 and B2) along the experimental period. We conclude that photobiomodulation therapy was able to promote the reduction of proinflammatory cytokines such as TNF-α and CINC-1, to reduce the gene and protein expression of the bradykinin receptor (B1 and B2), as well as increasing the stimulus response threshold of pressure in an experimental model of acute osteoarthritisKeywords
Funding Information
- São Paulo Research Foundation (2015/13677-4)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (309065/2015-1)
This publication has 35 references indexed in Scilit:
- Effect of low-level laser therapy on metalloproteinase MMP-2 and MMP-9 production and percentage of collagen types I and III in a papain cartilage injury modelLasers in Medical Science, 2013
- Modulating effect of low level-laser therapy on fibrosis in the repair process of the tibialis anterior muscle in ratsLasers in Medical Science, 2013
- Infrared low-level diode laser on inflammatory process modulation in mice: pro- and anti-inflammatory cytokinesLasers in Medical Science, 2012
- The Effect of Bradykinin B2 Receptor Polymorphisms on the Susceptibility and Severity of Osteoarthritis in a Chinese CohortJournal of Biomedicine and Biotechnology, 2012
- Fasitibant chloride, a kinin B2 receptor antagonist, and dexamethasone interact to inhibit carrageenan-induced inflammatory arthritis in ratsBritish Journal of Pharmacology, 2012
- Anti‐inflammatory synergy of MEN16132, a kinin B2 receptor antagonist, and dexamethasone in carrageenan‐induced knee joint arthritis in ratsBritish Journal of Pharmacology, 2010
- Bradykinin and B2 receptor antagonism in rat and human articular chondrocytesBritish Journal of Pharmacology, 2010
- OsteoarthritisJournal of Cellular Physiology, 2007
- Atorvastatin inhibits inflammatory hypernociceptionBritish Journal of Pharmacology, 2006
- Inhibition of rats adjuvant arthritis by a bradykinin antagonist hoe 140 and its influence on kallikreinsGeneral Pharmacology: The Vascular System, 1996